Medtronic wins CE mark for OmniaSecure defibrillation lead

The device maker designed the lead to have the safety benefits of small-diameter devices without sacrificing durability.
MassDevice

Medtronic wins expanded FDA approval for OmniaSecure for conduction pacing

Medtronic announced today that it received FDA approval for an expanded indication for its OmniaSecure defibrillation lead.

Medtronic’s OmniaSecure defibrillation lead earns expanded FDA indication

The OmniaSecure lead gained the first U.S. approval for placement in the heart’s left bundle branch area, to help activate ...
Medical Device Network on MSN

Medtronic’s OmniaSecure defib lead nets another FDA approval

OmniaSecure is now the first defibrillation lead approved for placement in the left bundle branch.
TCTMD

Largest Randomized Clinical Trial Of Implantable Cardioverter Defibrillator Recipients Demonstrates Excellent Patient Outcomes With Or Without Defibrillation Testing

Boston Scientific Shockless Implant Evaluation (SIMPLE) Study Results Presented at Heart Rhythm 2014, the Heart Rhythm Society's 35th Annual Scientific Sessions The trial results demonstrated that ...